Opendata, web and dolomites


New antiperspirant efficacy evaluation techniques based on a disruptive microfluidic technology

Total Cost €


EC-Contrib. €






 SUDOCHIP project word cloud

Explore the words cloud of the SUDOCHIP project. It provides you a very rough idea of what is the project "SUDOCHIP" about.

subjects    protocol    techniques    create    turnover    sweat    reproducible    sales    natural    explore    few    industry    87    suppliers    predefined    vivo    formulations    standard    precisely    technique    instrument    minutes    sweating    unreliable    successfully    almost    mimics    commercial    drive    considerable    ap    time    performed    prototype    microfactory    10k    gold    accelerate    phase1    ingredients    aluminium    business    40    groups    regulates    dominate    fear    free    validated    food    carcinogenic    smes    adults    generate    jobs    twenty    marketing    consuming    administration    skin    world    perfectly    raw    axillae    last    direct    cosmetic    cancer    finalise    hot    aps    market    antiperspirants    20bn    cheaper    human    volunteers    36    2015    drug    faster    reduce    paradigm    efficacy    countries    artificial    efforts    leaders    changed    components    requesting    room    measured    road    validation    hundred    2023    global    gravimetry    international    armpit    prioritise    otherwise    first    unadapted    microfluidic    invented    expensive    million    exempt   

Project "SUDOCHIP" data sheet

The following table provides information about the project.


Organization address
address: 10 RUE VAUQUELIN
city: PARIS
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2018-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROFACTORY FR (PARIS) coordinator 50˙000.00


 Project objective

Antiperspirants (APs) are among the most widely used cosmetic products that reduce sweat in the axillae (€20bn market in 2015). They are used by almost 90 % of the adults in developed countries. The Food and Drug Administration regulates APs, and gravimetry is the gold standard technique used to test them. More precisely, a direct application of the test sample on the armpit is performed on 40 volunteers and sweating is measured under predefined conditions in a hot room. This technique, which has not changed for the last twenty years, is time-consuming (a month), expensive (up to 10K€), and unreliable (/- 40%). Due to consumer fear that aluminium in APs may cause cancer, aluminium-free, “natural” APs will dominate the market. A change of paradigm is down the road, requesting the design and test of a considerable number of new formulations, for which the existing methods are clearly unadapted. Microfactory has invented a new microfluidic instrument and AP efficacy testing protocol using natural or artificial sweat that perfectly mimics the in vivo skin sweating process. The test does not require human subjects, is one hundred time faster (few minutes), is cheaper than other techniques, and is highly reproducible. The first prototype has been successfully validated by two world leaders in the cosmetic industry. It will accelerate the design of new antiperspirants with more natural ingredients exempt of carcinogenic components, that would otherwise take many years to develop using the current techniques. The Phase1 objective is to finalise instrument validation over a new range of aluminium free commercial APs and to explore and prioritise new market applications. For Microfactory, it will open new global business opportunities with major international cosmetic groups, SMEs and suppliers of raw cosmetic ingredients. It will generate an ambitious turnover of €36 million in 2023, as well as create 87 new European jobs to drive development, marketing and sales efforts.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUDOCHIP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUDOCHIP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)


Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More